Abstract
Lung cancer is the largest cancer killer of men and women. In addition to the progress made from anti smoking campaigns, new tools to diagnose and treat patients are emerging which have made rapid advances in the knowledge of molecular pathogenesis of lung cancer. These tools have started to provide an insight into how the tumor cell, by altering oncogenes and tumor suppressor genes, achieves growth advantage, uncontrolled proliferation and metastatic behaviour. Now knowledge is being gathered in terms of the molecular definition of individual susceptibility to tobacco smoke carcinogens. This review summarizes current knowledge of the molecular pathogenesis of lung cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Albanell, J., Lonardo, F., Rusch, V., Engelhardt, M., Langenfeld, J., Han, W. et al. (1997) High telomerase activity in primary lung cancers: association with increased cell proliferation rates and advanced pathologic stage. J. Natl. Cancer Inst. 9: 1609-1615.
Angeletti, C.A., Lucchi, M., Fontanini, G., Mussi, A., Chella, A., Ribechine, A. et al. (1996) Prognostic significance of tumoral angiogenesis in completely resected late stage lung carcinoma (Stage IIIA-N2): impact of adjuvant therapies in a subset of patients at high risk of recurrence. Cancer 78: 409-415
Apolinario, R.M., Van der Valk, P., De Jong, J.S., Deville, W., Van Ark-Otte, J., Dingemans, A.M. et al. (1997) Prognostic value of the expression of p53, bcl-2, and BAX oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer. J. Clin. Oncol 15: 2456-2466
Awasthi, Y.C., Singh, S.V., Ahmad, H. and Moller, P.C. (1987) Immunohistochemcial evidence for the expression of GST1, GST2, GST3 gene loci for gluathione-S-transferase in human lung. Lung 95: 323-332.
Bale, A.E., Nerbert, P.W., and Mcbride, O.W. (1987) Subchromosomal localization of the dioxin inducible P450 locus (CYP1) and description of two RFLPs detected with a 3' P1450 cDNA probe. Cytogenet. Cell Genet. 46: 574-575
Belinsky, S.A., Nikula, K.J., Palmisano, W.A., Michels, R., Saccomanno, G., Gabrielson, E. et al. (1998) Abberrantmethylation of p16(ink4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc. Natl. Acad. Sci. 95: 11891-11896
Bell, D.A., Taylor, J.A., Paulson, D.F., Robertson, A.N., Mohler, J.C. Lucier, J.W. (1996) Genetic risk and carcinogen exposure: A common inherited defect of carcinogen-metabolism gene glutathione S-transferase Mc (GSTM1) that increases susceptibility to bladder cancer. J. Natl. Cancer Inst. 85: 1159-1164
Bennett, W.P., El-Deiry, W.S., Rush, W.L., Guinee, D.G.J. et al. (1998) p21 wafl/cip1 and transforming growth factor b\ protein expression correlate with survival in non-small cell lung cancer. Clin. Cancer Res. 4: 1499—506.
Bennett, W.P., Hussain, S.P., Vahakangas, K.H., Khan, M.A., Shields, P.G. and Harris, C.C. (1999) Molecular epidemiology of human cancer risk: gene-environment interactions and p53 mutation spectrum in human lung cancer. J. Pathol 197: 8-18
Betticher, D.C., Heighway, J., Hasleton, P.S., Altermatt, H.J., Ryder, W.D., Cerny, T. et al. (1996) Prognostic significance of CCND1 (cyclin Dl) overexpression in primary resected non-small-cell lung cancer. Br. J. Cancer 73: 294-300
Brookes, P. and Lawley, P.D. (1964) Evidence for the binding of polynuclear aromatic hydrocarbons to nucleic acid of mouse skin: relation between carcinogenic power of hydrocarbons and their binding to deoxyribonucleic acid. Nature 202: 781-784
Burke, L., Khan, M. A., Freedma, A.N., Gemma, A., Rusin, M. et al. (1998) Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer. Cancer Res. 58: 2533-2536
Caputi, M., Esposito, V., Baldi, A., De, L.A., Dean, C., Signoriello, G. et al. (1998) p2l waf1/cip1 mdm-6 expression in non-small-cell lung cancer: relationship to survival. Am. J. Respir. Cell Mol. Biol. 18: 213-217
Caputi, M., Groeger, A.M., Esposito, V., Dean, C., De Luca, A., Pacilio, C. et al. (1999) Prognostic role of cyclin D\ in lung cancer: relationship to proliferating cell nuclear antigen. Am. J. Respir. Cell Mol. Biol 20: 746-750.
Chandrachud, L.M., Pendleton, N., Chisholm, D.M., Horan, M.A. and Schor, A.M. (1997) Relationship between vascularity, age and survival in non-small-cell lung cancer. Br. J. Cancer 76: 1367-1375
Conney, A.H. (1989) Induction of microsomal enzymes by foreign chemicals and carcinogensis by polycyclic aromatic hydrocarbons. Clowes Memorial Lecture. Canc. Res. 42: 4875-4917
Coombs, M.M. (1986) Organ specificity in tumor initiation of complete carcinogenesis (including species variation) In: Target Tixicity (Ed G.M. Cohen) 2: 181-208
. Cuttitta, F., Carney, D.N., Mulshine, J., Moody, T.W., Fedorko, J., Fischler, A. et al. (1985) Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature 316: 823-826
Czerwinski, M., McLemore, T.L., Gelbolin, H., Gonzalez, F.J. (1994) Quantification of CYP2B7, CYP4B1 and CYPOR messenger RNAs in normal human lung and lung tumor. Canc. Res. 54: 1085-1091
Dosaka-Akita, H., Hu, S-X., Fujino, M., Harada, M., Kinoshita, I., Xu, H-J. et al. (1997) Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered RAS and p53 protein status on prognosis. Cancer 79: 1329-1337
Esteller, M., Sanchez-Cespedes, M., Rosell, R., Sidransky, D., Baylin, S.B. and Herman, J.G. (1999) Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res. 59: 67-70
Fathi, Z., Way, J.W., Corjay, M.H., Viallet, J., Sausville, E.A. and Battey, J.F. (1996) Bombesin receptor structure and expression in human lung carcinoma cell lines. J. Cell Biochem. Suppl. 24: 237-246
Fong, K.M., Biesterveld, E.J., Virmani, A., Wistuba, I., Sekido, Y., Bader, S.A. et al. (1997) Fhit and FRA3B 3pl4.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related fhit cDNA splicing aberrations. Cancer Res. 57: 2256-2267
Fontanini, G., Lucchi, M., Vignati, S., Mussi, A., Ciardiello, F., De Laurentiis, M. et al. (1997) Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: A prospective study. J. Natl. Cancer Inst. 89: 881-886
Fontanini, G., Vignati, S., Lucchi, M., Mussi, A., Calcinai, A., Boldrini, L. et al. (1997) Neo-angiogenesis and p53 protein in lung cancer: their prognostic role and its relation with vascular endothelial growth factor (VEGF) expression. Br. J. Cancer 75: 1295-1301
Gazzeri, S., Delia, Valle, V., Chaussade, L., Brambilla, C., Larsen, C.J. and Brambilla, E. (1998) The human pl9ARF protein encoded by the beta transcript of the p16INK4a gene is frequently lost in small cell lung cancer. Cancer Res. 58: 3926-3931
Gearadts, J., Fong, K.M., Zimmerman, P.V., Maynard, R. and Minna, J.D. (1999) Correlation of abnormal Rb, p16INK4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities and clinical features in 103 primary non-small cell lung cancers. Clin. Cancer Res. 5: 791-800
Goshmann, L.M. and Heidelberger, C. (1967) Binding of tritium—labeled polycyclic hydrocarbons DNA of mouse skin Cancer Res. 24: 1678-1688
Graziano, S.L., Gamble, G.P., Newman, N.B., Abbott, L.Z., Rooney, M., Mookherjee, S. et al. (1999) Prognostic significance of K-ras codon 12 mutations in patients with resected stage I and II non-small-cell lung cancer. J. Clin. Oncol 17: 228-232
Greenblatt, M.S., Bennett, W.P., Hollstein, M. and Harris, C.C. (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54: 4855-4878
Halmos, G. and Schally, A.V. (1997) Reduction in receptors for bombesin and epidermal growth factor in xenografts of human small-cell lung cancer after treatment with bombesin antagonist RC-3095. Proc. Natl Acad. Sci. USA 94: 956-960
Harbour, J.W., Lai, S.L., Whang-Peng, J., Gazdar, A.F., Minna, I.D. and Kaye, F.J. (1998) Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science 241: 353-357
Haugen, A., Borresen, A.L., Willey, J., Tetre, T.C. (1991) Pst I polymorphism at the human P450 gene on chromosome 15, Nucleic. Acid and Res. 18: 3114-3116
Hibi, K., Takahashi, T., Yamakawa, K., Ueda, R., Sekido, Y., Ariyoshi, Y. et al. (1992) Three distinct regions involved in 3p deletion in human lung cancer. Oncogene 71: 27-92.
Higashiyama, M., Doi, O., Kodama, K., Yakouchi, H., Nakamoris, S. and Tateishi, R. (1997) Bcl-2 oncoprotein in surgically resected non-small cell lung cancer: possibly favorable prognostic factor in association with low incidence of distant metastasis. J. Surg. Oncol 64: 48-54
Hiyama, K., Hiyama, E., Ishioka, S., Yamakido, M., Inai, K., Gazdar, A.F. et al. (1995) Telomerase activity in small-cell and non-small-cell lung cancers. J. Natl. Cancer Inst. 87: 895-902
Huvonen, H., Husgafvel, P., Karjulaienen, K. Vainio, H. (1992) Point mutational mspI and lle/Val polymorphism closely linked in Cyp 1a1 gene: lack of association with susceptibility to lung cancer in a Finnish study population. Cancer Epidemiol. Biomarkers Prev. 1: 485-489
Jaiswal, A.K., Gonzalez, F.J. and Nebert, D.W. (1985) Human p450 gene sequence and correlation of mRNA with genetic differences in benzo (a) pyrene metabolism Nucleic Acid Res. 13: 4503-4520
Ji, L., Fang, B., Yen, N., Fong, K., Minna, J.D. and Roth, J.A. (1999) Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression [In Process Citation]. Cancer Res. 59: 3333-3339
Jiang, S.X., Kameya, T., Sato, Y., Yanase, N., Yoshiura, H. and Kodama, T. (1996) Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation. Am. J. Pathol. 148: 837-846
Johnson, B.E., Russell, E., Simmons, A.M., Phelps, R., Steinberg, S.M., Ihde, D.C. et al. (1996) Myc family DNA amplification in L-myc gene regulation in small cell lung cancer. Oncogene 13: 1893-1899
Kaiser, U., Schilli, M., Haag, U., Neumann, K., Kreipe, H., Kogan, E. et al. (1996) Role of bcl-2 protein in small cell lung cancer. Lung Cancer 15: 31-40
Kawajiri, K., Nakachi, K., Tmai, K., Hayashi, S. and Watanabe, J. (1991) Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res. 51: 5177-5180
Kelley, M.J., Linnoila, R.I., Avis, I.L., Georgiadis, M.S., Cuttitta, F., Mulshine, J.L. et al. (1997) Antitumor activity of a monoclonal antibody directed against gastrin-releasing peptide in patients with small cell lung cancer. Chest 112: 256-261
Kennerh, D.T. (1994) Glutathione-associated enzymes in anti-cancer drug resistance.54: 4313-4320
Kohno, T., Kawanishi, M., Inazawa, J. and Yokota, J. (1998) Identification of CpG islands hypermethylated in human lung cancer by the arbitrarily primed-PCR method. Hum. Genet. 102: 258-264
Kok, K., Naylor, S.L. and Buys, C.H. (1997) Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes. Adv. Cancer Res. 71: 72-92
Kok, K., van Den Berg, A., Veldhuis, P.M.J.F., van der Veen, A.Y., Franke, M., Schoenmakers, E.F.P.M. et al. (1994) A homozygous deletion in a small cell lung cancer cell line involving a 3p21 region with a marked instability in yeast artificial chromosomes. Cancer Res. 54: 4183-4187.
Kondo, M., Suzuki, H., Ueda, R., Osada, H., Takagi, K., Takahashi, T. et al. (1995) Frequent loss of imprinting of the H19 gene is often associated with its overexpression in human lung cancers. Oncogene 10: 1193-1198
Koukourakis, M.I., Giatromanolaki, A., O'Byrne, K.J., Comley, M., Whitehouse, R.M., Talbot, D.C. et al. (1997) Platelet-derived endothelial cell growth factor expression correlates with tumor angiogenesis and prognosis in non-small-cell lung cancer. Br. J. Cancer 75: 477-481.
Kouri, R.E., Levine, A.S. and Edwards, B.K. (1984) Source of inter-individual variation in asyl hydrocarbon hydroxylase in mitogen activated human lymophocytes. In: Bambury Report 16: Genetic variability in Response to chemical exposure (Omevum, G., Gelbolin, H.) Cold Spring Harbor NY 131-144
Kouri, R.E., Lobet, R. A. Mckinney, E.C. (1983) Aryl hydrocarbon hydroxylase of mice and humans. In: Application of Biological Markers to Carcinogen Testing (Eds Milmann AA Sells) New York Plenum Press 179-197
Kouri, R.E., M.C., Lemore, T. and Jaiswal, A.K. (1986) Current cellular assays for measuring clinical drug metabolising capacity: Impact of new molecular biological techniques. In: Reaction to Drugs and Xenobiotics New York. Alan. R. Liss. 453-469.
Kratzke, R.A., Createns, T.M., Rubins, J.B., Maddaus, M.A., Niewoehner, D.E., Niehans, G.A. et al. (1996) Rb and pl6INK4a expression in resected non-small cell lung tumors. Cancer Res. 56: 3415-3420
Lengauer, C., Kinzler, K.W. and Vogelstein, B. (1998). Genetic instabilities in human cancers. Nature 396: 643-649
Levin, N.A., Brzoska, P.M., Wornock, M.L., Gray, J.W. and Chirstman, M.F. (1995) Identification of novel region of altered DNA copy number in small cell lung tumors. Genes, Chromosomes Cancer 13: 175-178.
Mai, M., Yokomizo, A., Qian, C, Yang, P., Tindall, D.J., Smith, D.I. et al. (1998) Activation of p73 silent allele in lung cancer. Cancer Res. 58: 2347-2349
Makos, M., Nelkin, B.D., Lerman, M.I., Latif, F., Zbar, B. and Baylin, S.B. (1992) Distinct hypermethylation patterns occurs at altered chromosome loci in human lung and colon cancer. Proc. Natl. Acad. Sci. 89: 1929-1933
Mannervik, B., Awasthi, V.C., Board, P.G., Hayes, J.D., Dillio, C., Ketterer, B., Listowsky, S., Morgenstern, R., Muranatsu, M., Pearson, W.R., Pickett, C.B., Sato, K., Widerstern, M. and Wolf, C.R. (1992) Nomenclature for human Glutathione S transferases. Biochem. J. 282: 305-308
Makos, M., Nelkin, B.D., Lerman, M.I., Latif, F., Zbar, B. and Baylin, S.B. (1992) Distinct hypermethylation patterns occurs at altered chromosome loci in human lung and colon cancer. Proc. Natl. Acad. Sci. 89: 1929-1933
Marchetti, A., Doglioni, C., Batbareschi, M., Buttitta, F., Pellegrini, S., Bertacca, G. et al. (1996) p21 RNA and protein expression in non-small cell lung carcinomas: evidence of p5 3-independent expression and association with tumoral differentiation. Oncogene 12: 1319-1324
Mattern, J., Koomagi, R. and Volm, M. (1996) Association of vascular endothelial growth factor expression with intratumoral microvessel density and increased cell proliferation in human epidermoid lung carcinoma. Br. J. Cancer 73: 961-964
Mclemore, T.L. and Martin, R.R. (1987) Pulmonary carcinogenesis: Aryl hydrocarbon hydoxylase In: Cancer Treatment and Research, Lung Cancer Livingstone RB (ed) The Hague: Martinus-Nijhoff 1-34
Merlo, A., Herman, J.G., Mao, L., Lee, D.J., Gabrielsori, E., Burger, P.C. et al. (1995) 5'CpG island methylation is associated with transcriptional silencing of the tumor suppressor pl6/CDKN2/MTSl in human cancer. Nature Med. 1: 686-692.
Meyer, D.J., Coles, B., Pemble, S.E., Gilmore, K.S., Fraser, G.M. Ketterer, B. (1991) Theta—a new class of glutathione-transferases purified from rat and man. Biochem. J. 274: 409-414.
Minimo, C., Bibbo, M., Claudio, P.P., De Luca, A. and Girdano, A. (1999) The role of pRB2/pl30 protein in diagnosing lung carcinoma on fine needle aspiration biopsies. Pathol Res. Pract. 195: 67-70
Takanashi, T., Takahashi, T., Domenico, D’Amico, Itsuo, Chiba, Dorothy, L., Buchhangen, and John, D. Minna (1990) Identificaiton of intronic point mutations as an alternative mechanism for p53 inactivation in lung cancer. J. Clin. Investi. 86: 363-369.
Mishina, T., Dosaka-Akita, H.M., Kinoshita, I., Hommura, F., Morikawa, T., Katoh, H. et al. (1999) Cyclin Dl expression in non-small-cell lung cancer: its association with altered p53 expression, cell proliferation and clinical outcome. Br. J. Cancer. 80: 1289-1295.
Morgernstern, K. and Depierre, J.C. (1988) Membrane bound glutathione transferases In: (Eds. Sies, J. Kettever, B.) Glutathione conjugation Mechanisms and Biological Significance. 157-174 New York Academic.
Nakachi, K., Tmai, K., Hayashi, S. and Kawajiri, K. (1993) Polymorphisms of the cyp 1a1 and glutathione-S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res. 53: 2994-2999.
Nakajama, T., Elvorara, E., Anttila, S., Hirvonene, A., Camus, A.M. and Hayes, J.D.C. (1995) Expression and polymorphism of glutathione-S-transferases in human lungs. Risk factors in smoking related lung cancer. Carcinogenesis 16: 707-711.
Nakayanam, J., Yospa, S.H. and Pairier, M.C. (1984) Benzo (a) pyrene-DNA adduct formation and removal in mouse epidermis: in vivo and in vitro relationship of DNA binding to initiation of skin carcinogenesis. Cancer Res. 44: 4087-4095.
Nambu, Y., Hughes, S.J., Rehemtulla, A., Hamstra, D., Orringer, M.B. and Beer, D.G. (1998) Lack of cell surface Fas/Apo-1 expression in pulmonary adenocarcinomas. J. Clin. Invest. 101: 1102-1110.
Nau, M.M., Brooks, B.J., Battey, J., Sausville, E., Gazdar, A.F., Kirsch, I.R. et al. (1985) L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer. Nature 318: 69-73.
Nelson, H.H., Weinoke, J.K., Christiani, D.C., Cheng, T.J., Zuo-ZF, Lee, B.K., Spitz, M.R., Wang, M., Xu, X. and Kelsey, K.T. (1995) Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione-S-transferases theta. Carcinogenesis 16: 1243-1245.
Nerbert, D.W. and Gonzalez, F.J. (1987) P450 genes: structure, evolution and regulation. Annu. Rev. Biochem. 56: 945-993.
Niehans, G.A., Brunner, T., Frizelle, S.P., Liston, J.C., Salerno, C.T., Knapp, D.J. et al. (1997) Human lung carcinomas express Fas ligand. Cancer Res. 57: 1007-12.
Norppa, H., Hirvonen, A., Jarventaus, H., Uskula, M., Tasa, G. and Sorsa, M. (1995) Role of GST1 and GSTM1 genotypes in de terming individual sensitivity to sister chromatid exchange induction by diepoxybutane in cultured human lymphocytes. Carcinogenes 6: 1261-1264.
O’Briant, K.C. and Bepler, G. (1997) Deletion of the centromeric and telomeric chromosome segment 11p715.5 in lung cancer suppressor regions LOH11A and LOHllB. Genes in Chromosomes, Cancer 18: 111-114.
Ohata, H., Emi, M., Fujiwar, Y., Higashino, K., Nakagawa, K., Futagami, R. et al. (1993) Deletion mapping of the short arm of chromosome 8 in non-small cell lung carcinoma. Genes. Chromosomes Cancer 7: 85-8.
Omiecinski, T.J., Redlich, C.A. and Custa, P.C. (1990) Induction and developmental expression of cytochrome P4501 Al messenger RNA in rat and human tissues, detection by the polymerase chain reaction. Cancer Res. 50: 4315-4321.
Otsuka, T., Kohno, T., Mori, M., Noguchi, M., Hirohashi, S. and Yokota, J. (1996) Deletion mapping of chromosome 2 in human lung carcinoma. Genes Chromosomes Cancer 16: 113-119.
Otterson, G.A., Khleif, S.N., Chen, W., Coxon, A.B. and Kaye, F.J. (1995) CDKN2 gene silencing in lung cancer by DNA hypermethylation and kinetics of pl6INK4 protein induction by 5-aza2' deoxycytidine. Oncogene 11: 1211-1216.
Otterson, G.A., Xiao, G.H., Geradts, J., Jin, F., Chen, W.D., Niklinska, W. et al (1998) Protein expression and functional analysis of the FHIT gene in human tumor cells. J. Natl. Cancer Inst. 90: 426-432.
Ou, X., Campau, S., Slusher, R., Jasti, R.K., Mabry, M. and Kalemkerian, G.P. (1996) Mechanism of all-trans-retinoic acid-mediated L-myc gene regulation in small cell lung cancer. Oncogene 13: 1893-1899.
Pastorino, U., Andreola, S., Tagliabue, E., Pezzella, F., Incarbone, M., Sozzi, G. et al (1997) Immunocytochemical markers in stage I lung cancer: relevance to prognosis. J. Clin. Oncol. 15: 2858-2865.
Pelkonen, O. Yahakangas, K. (1980) Binding of polycyclic aromatic hydrocarbons to DNA: comparison of mutagenesis and tumor genesis. J. Toxicol. Environ. Health 6: 1009-1020.
Pemble, S., Schroeder, K.R., Spencer, S.R., Meyer, P.J., Hallier, E., Bolt, H.M., Ketterer, B. and Taylor, J.B. (1994) Human glutathione-S-transferase theta (GSTT1) cDNA cloning and the characterisation of genetic polymorphism. Biochem. J. 300: 271-1248.
Pezzella, F., Turley, H., Kuzu, I., Tungekar, M.F., Dunnill, M.S., Pierce, C.B. et al. (1993) Bcl-2 protein in non-small-cell lung carcinoma. N Engl. J. Med. 329: 690-694.
Rachwal, W.J., Bongiorno, P.F., Orringer, M.B., Whyte, R.I., Ethier, S.P. and Beer, D.G. (1995) Expression and activation of erb b-2 and epidermal growth factor receptor in lung adenocarcinomas. Br. J. Cancer 72: 56-64.
Randa, E., Nivea, C.F. and Willam, W.A. (1997) Interactions between genetic predisposition and environmental toxicants for development of lung cancer. Environmental and Molecular Mutagenesis 30: 196-204.
Raunio, H., Husgafvel, P., Anttila, S., Selkoen, O., Hirvonen, A. (1995) Diagnosis of polymorphism in carcinogen activating and inactivating enzymes and cancer susceptibility: Gene. 159: 113-121.
Richardson, G.E. and Johnson, B.E. (1993) The biology of lung cancer. Semin Oncol. 20: 105-127.
Rosell, R., Li, S., Skacel, Z., Mate, J.L., Maestre, J., Canela, M. et al. (1993) Prognostic impact of mutated Kras gene in surgically resected non-small cell lung cancer patients. Oncogene 8: 2407-2412.
Sato, S., Nakamura, Y. and Tsuchiya, E. (1994) Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung. Cancer Res. 54: 5652-5655.
Seidegard, J., Pero, R.W., Markowitz, M., Rouch, G., Miller, D.G., Beattie, E.J. (1990) Isoenzymes of glutathione transferases (Mu) as a marker of the susceptibility of lung cancer, a follow up study. Carcinogensis 11: 33-36.
Seidegard, J., Pero, R.W., Miller, D.G. and Beattie, E.J. (1986) A glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancer. Carcinogenesis 7: 751-753.
Shen, A.L., Fahl, W.E. and Jefcoatte, C.K. (1980) Metabolism of benzo (a) pyrene by isolated hepatocytes and factors affecting covalent binding of benzo (a) pyrene metabolites to DNA in hepatocyte and microsomal systems. Arch. Biochem. Biophys. 204: 511-523.
Siegfried, J.M., Gillespie, A.T., Mera, R., Casey, T.J., Keohavong, P., Testa, J.R. et al. (1997) Prognostic value of specific K-ras mutations in lung adenocarcinomas. Cancer Epidemiol. Biomarkers Prev. 6: 841-847.
Siprashvili, Z., Sozzi, G., barnes, L.D., McCune, P., Robinson, A.K., Eryomin, V. et al. (1997) Replacement of FHIT in cancer cells suppresses tumorigenecity. Proc. Natl. Acad. Sci. USA 94: 13771-13776.
Smith, C.M., Kelsey, K.T., Weincke, J.K., Leyden, K., Levin, S. and Christiani, D.C. (1994) Inherited gluathione S-transferase deficiency is a risk factor for pulmonary asbestosis. Cancer Epidemiol. Biomarkers Prev. 3: 471-477.
Sozzi, G., Sard, L., De Gregorio, L., Marchetti, A., Musso, K., Buttitta, F. et al. (1997) Association between cigarette smoking and fhit gene alterations in lung cancer. Cancer Res. 57: 5207-5212.
Sozzi, G., Tornielli, S., Tagliabue, E., Sard, L., Pezzella, F., Pastorino, U. et al. (1997) Absence of FHIT protein in primary lung tumors and cell lines with fhit gene abnormalities. Cancer Res. 57: 5207-5212.
Sozzi, G., Veronese, M.L., Negrini, M., Baffa, R., Cotticelli, M.G., Inoue, H. et al. (1996) The fhit gene3p14.2 is abnormal in lung cancer. Cell 85: 17-26.
Spur, N.K., Gough, A.C. and Wolf, C.K. (1987) Msp1 polymorphism detected with cDNA probe for the P-450 family on chromosome 15. Nucleic acid Res 15: 5901-5905.
Stewart, V.N., Motulsky, A.G., Eaton, D.L., White, E., Hornung, S.K., Zhong, T.L., Stapelton, P. Weiss, N.S. (1993) The glutathione-S-transferase m polymorphism as a marker for susceptibility to lung carcinoma. Cancer Res. 53: 2313-2318.
Strange, R.C., Davis, B.A. and Faulder, C.G. (1985) The human glutathione-S-transferase: developmental aspects of the GST1, GST2, GST3, loci. Biochem. Genet. 23: 1011-1028.
Strange, R.C., Faulder, C.G. and Davis, B.A. (1984) The human glutathione-S-transferases: Studies on the distribution and genetic variation of the GSTl, GST2, and GST3 isoenzymes Ann. Hum. Genet. 48: 11-20.
Suprzem, J.R., Rennard, S.I. and Romberger, D.J. (1997) Bombesin-like peptides and airway repair: a recapitulation of lung development. Am. J. Respir. Cell Mol. Biol. 16: 209-211.
Suzuki, H., Ueda, R., Takahashi, T. and Takahashi, T. (1994) Altered imprinting in lung cancer. Nature Genet. 6: 332-335.
Taga, S., Osaki, T., Ohgami, A., Lmoto, H., Yoshimatsu, T., Yoshino, I. et al. (1997) Prognostic value of the immunohistochemical detection of p16INK4 expression in non-small cell lung carcinoma. Cancer 80: 389-95.
Takahashi, T., Nau, M.M., Chiba, I., Birrer, M.J., Rosenberg, R.K., Vinocour, M. et al., (1989) p53: a frequent target for genetic abnormalities in lung cancer. Science 246: 491-494.
Tokuchi, Y., Kobayashi, Y., Hayashi, S., Hayashi, M., Tanimoto, K., Hashimoto, T. et al. (1999) Abnormal flhit transcripts found in both lung cancer and normal lung tissue. Gene Chromosomes Cancer 24: 105-11.
Tsai, C-M., Chang, K-T., Wu, L-H., Chen, J-Y., Gazdar, A.F., Mitsudomi T. et al (1996) Correlations between intrinsic chemoresistance and HER-2/neu gene expression, p53 gene mutations, and cell proliferation characteristics in non-small cell lung cancer lines. Cancer Res. 56: 206-209.
Tsuchiya, E., Furuta, R., Wada, N., Ishikawa, Y., Kawabuchi, B. et al. (1995) High K-ras mutation rates in goblet-cell-type adenocarcinomas of the lungs. J. Cancer Res. Clin. Oncol. 121: 577-81.
Ueno, K., Kumagai, T., Kijima, T., Kishimoto, T. and Hosoe, S. (1998) Cloning and tissue expression of cDNAs from chromosome 5q21-22 which is frequently deleted in advanced lung cancer. Hum. Genet. 102: 63-68.
Virmani, A.K., Fong, K.M., Kodagoda, D., Mclntire, D., Hung, J. and Tonk, V. et al. (1998) Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types. Genes. Chromosomes Cancer 21: 308-19.
Volm, M., Koomagi, R., Mattern, J., Stammler, G. (1997) Prognostic value of basic fibroblast growth factor and its receptor (FGFR-1) in patients with non-small-cell lung carcinomas. Eur. J. Cancer 33: 691-3.
Wang, S.S., Esplin, E.D., Li, J.L., Huang, L., Gazdar, A. and Minna, J. et al. (1998) Alterations of the ppp2rib gene in human lung and colon cancer. Science 282: 284-7.
Wei, M-H., Latif, F., Bader, S., Kashuba, V., Chen, J-Y., Duh, F-M. et al. (1996) Construction of a 600-kilobase cosmid clone contig and generation of a transcriptional map surrounding the lung cancer tumor suppressor gene (TSG) locus on human chromosome 3p21.3: progress toward the isolation of a lung cancer TSG. Cancer Res. 56:1487-92.
Weiner, D.B., Nordberg, J., Robinson, R., Nowell, P.C., Gazdar, A. and Greene, M.I. et al. (1990) Expression of the new gene-encoded protein (P185neu) in human non-small cell carcinomas of the lung. Cancer Res. 50: 421-5.
Wistuba, I.I., Behrens, C., Virmani, A.K., Milchgrub, S., Syed, S. and Lam, S. et al. (1999) Allelic losses at chromosome 8p21-23 are early and frequent events in the pathogenesis of lung cancer. Cancer Res. 59: 1973-9.
Yashima, K., Litzky, L.A., Kaiser, L., Rogers, T., Lam, S. and Wistuba, I.I. et al. (1997) Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinomas. Cancer Res. 57: 2373-7.
Yoshikawa, H., Nagashima, M., Khan, M.A., McMenamin, M.G., Hagiwar, K. and Harris, C.C. (1999) Mutational analysis of p73 and p53 in human cancer cell lines. Oncogene 18: 3415-21.
Yu, D., Wang, S-S., Dulski, K.M., Tsai, C-M., Nicolson, G.L. and Hung, M-C. (1994) c-erbb B-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties. Cancer Res. 54: 3260-6.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Narosa Publishing House, New Delhi, India
About this chapter
Cite this chapter
Sobti, R.C., Sharma, S., Janmeja, A.K., Jindal, S.K. (2002). Molecular Pathogenesis of Lung Cancer. In: Sobit, R.C., Obe, G., Athwal, R.S. (eds) Some Aspects of Chromosome Structure and Functions. Springer, Dordrecht. https://doi.org/10.1007/978-94-010-0334-6_18
Download citation
DOI: https://doi.org/10.1007/978-94-010-0334-6_18
Publisher Name: Springer, Dordrecht
Print ISBN: 978-0-7923-7057-4
Online ISBN: 978-94-010-0334-6
eBook Packages: Springer Book Archive